Patents by Inventor Tamas Koltai

Tamas Koltai has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Crystalline solid rasagiline base
    Publication number: 20100145101
    Abstract: The subject invention provides crystalline R(+)-N-propargyl-1-aminoindan, pharmaceutical compositions and methods of manufacture thereof.
    Type: Application
    Filed: January 8, 2010
    Publication date: June 10, 2010
    Inventors: Anton Frenkel, Tamas Koltai
  • Candesartan cilexetil polymorphs
    Publication number: 20100121072
    Abstract: Provided are candesartan cilexetil forms and methods of their preparation. Also provided are pharmaceutical compositions prepared by combining at least one pharmaceutically-acceptable excipient with at least one candesartan cilexetil form of the invention.
    Type: Application
    Filed: January 13, 2010
    Publication date: May 13, 2010
    Inventors: Marina Yu Etinger, Boris Fedotev, Tamas Koltai, Ziv Kurgan, Omer Malachi
  • CRYSTALLINE FORMS OF DEXLANSOPRAZOLE
    Publication number: 20100113527
    Abstract: Provided are crystalline forms of dexLansoprazole, as well as processes for the preparation thereof.
    Type: Application
    Filed: September 30, 2009
    Publication date: May 6, 2010
    Inventors: Jacob RENDELL, Ariel MITTELMAN, Rinat MOSHKOVITS-KAPTSAN, Sergei FINE, Ana KWOKAL, Tamas KOLTAI
  • Candesartan cilexetil polymorphs
    Patent number: 7692023
    Abstract: Provided are candesartan cilexetil forms and methods of their preparation. Also provided are pharmaceutical compositions prepared by combining at least one pharmaceutically-acceptable execipient with at least one candesartan cilexetil form of the invention.
    Type: Grant
    Filed: February 11, 2005
    Date of Patent: April 6, 2010
    Assignee: Teva Pharmaceutical Industries Ltd.
    Inventors: Marina Yu Etinger, Boris Fedotev, Tamas Koltai, Ziv Kurgan, Omer Malachi
  • Fluvastatin sodium crystal forms, processes for preparing them, compositions containing them and methods of using them
    Patent number: 7687642
    Abstract: Provided are crystalline forms of fluvastatin sodium and processes for their preparation.
    Type: Grant
    Filed: January 29, 2007
    Date of Patent: March 30, 2010
    Assignee: Teva Pharmaceutical Industries Ltd.
    Inventors: Revital Lifshitz-Liron, Tamas Koltai, Judith Aronhime, Nurit Perlman, Sharon Avhar-Maydan
  • Crystalline ziprasidone HCl and processes for preparation thereof
    Patent number: 7678799
    Abstract: Provided is crystalline ziprasidone HCl and processes for preparation thereof.
    Type: Grant
    Filed: June 3, 2004
    Date of Patent: March 16, 2010
    Assignee: Teva Pharmaceutical Industries Ltd.
    Inventors: Anna Balanov, Judith Aronhime, Boaz Gome, Tamas Koltai, Natalia Shenkar, Marioara Mendelovici, Ehud Amir
  • POLYMORPHIC FORMS OF LADOSTIGIL TARTRATE
    Publication number: 20090275653
    Abstract: The invention provides for solid state chemistry of ladostigil tartrate, particularly polymorphic forms of ladostigil tartrate, and processes for the preparation thereof.
    Type: Application
    Filed: May 27, 2009
    Publication date: November 5, 2009
    Inventors: Judith ARONHIME, Eliezer Bahar, Anton Frenkel, Ronen Gottesfeld, Amir Gold, Tamas Koltai
  • Fluvastatin sodium crystal forms, processes for preparing them, compositions containing them and methods of using them
    Publication number: 20090209611
    Abstract: Provided are crystalline forms of fluvastatin sodium and processes for their preparation.
    Type: Application
    Filed: March 25, 2009
    Publication date: August 20, 2009
    Inventors: Revital Lifshitz-Liron, Tamas Koltai, Judith Aronhime, Nurit Perlman, Sharon Avhar-Maydan
  • Tannate salt of rasagiline
    Patent number: 7547806
    Abstract: The subject invention provides rasagiline tannate, compositions and a process for manufacture thereof.
    Type: Grant
    Filed: December 13, 2007
    Date of Patent: June 16, 2009
    Assignee: Teva Pharmaceutical Industries, Ltd.
    Inventors: Anton Frenkel, Tamas Koltai
  • Fluvastatin sodium crystal forms, processes for preparing them, compositions containing them and methods of using them
    Publication number: 20090118518
    Abstract: Provided are crystalline forms of fluvastatin sodium and processes for their preparation.
    Type: Application
    Filed: April 30, 2008
    Publication date: May 7, 2009
    Inventors: Revital Lifshitz-Liron, Tamas Koltai, Judith Aronhime, Nurit Perlman, Sharon Avhar-Maydan
  • POLYMORPHS OF DASATINIB AND PROCESS FOR PREPARATION THEREOF
    Publication number: 20090118297
    Abstract: Provided is dasatinib, solvates thereof and their crystalline forms, methods for their preparation, and pharmaceutical compositions thereof.
    Type: Application
    Filed: October 23, 2008
    Publication date: May 7, 2009
    Inventors: Ondrej SIMO, Jiri Filipcik, Alexandr Martaus, Alexandr Jegorov, Ales Gavenda, Judith Aronhime, Pavel Vraspir, Tamas Koltai, Jiri Faustmann, Roman Gabriel
  • Amorphous and crystalline forms of ibandronate disodium
    Publication number: 20090118239
    Abstract: Provided are amorphous and crystalline forms of ibandronate disodium, as well as processes for the preparation thereof.
    Type: Application
    Filed: May 15, 2008
    Publication date: May 7, 2009
    Inventors: Sharon Avhar-Maydan, Claude Singer, Tamas Koltai
  • Crystalline forms of ibandronic acid and processes for the preparation thereof
    Publication number: 20090099390
    Abstract: A crystalline ibandronic acid characterized by data selected from the group consisting of at least one of a powder x-ray diffraction pattern having peaks at about 4.1, 12.3 and 13.4±0.2 degrees two-theta and at least two more peaks selected from the group consisting of: 8.2, 11.3, 16.2 and 16.9 and 20.8±0.2 degrees two-theta, and by a powder X-ray diffraction pattern depicted in FIG. 1 is provided. Also provided is a crystalline ibandronic acid characterized by data selected from the group consisting of at least one of a powder x-ray diffraction pattern having peaks at about peaks at about 5.2, 11.7, and 18.7±0.2 degrees two-theta and at least two more peaks selected from the group consisting of: 5.8, 10.1, 12.0, 17.1, and 20.0±0.2 degrees two-theta and a powder X-ray diffraction pattern as depicted in FIG. 2. Methods of preparing the crystalline forms are also provided.
    Type: Application
    Filed: September 24, 2008
    Publication date: April 16, 2009
    Inventors: Claude Singer, Sharon W. Avhar-Maydan, Tamas Koltai, Amir Gold
  • Polymorphs of eszopiclone malate
    Publication number: 20090076272
    Abstract: The present invention provides crystalline Eszopiclone malate form II, crystalline Eszopiclone form V, processes from preparing the crystalline Eszopiclone malate form II or V, pharmaceutical compositions comprising the crystalline Eszopiclone malate form II or V and methods of treating insomnia comprising administering the crystalline Eszopiclone malate form II or V.
    Type: Application
    Filed: November 7, 2008
    Publication date: March 19, 2009
    Inventors: Marioara Mendelovici, Anita Lieberman, Tamas Koltai
  • Crystalline forms of ibandronate sodium
    Publication number: 20090042839
    Abstract: Provided are crystalline forms of ibandronate sodium, as well as processes for the preparation thereof.
    Type: Application
    Filed: May 15, 2008
    Publication date: February 12, 2009
    Inventors: Sharon Avhar-Maydan, Claude Singer, Tamas Koltai, Alexandr Jegorov
  • Crystalline forms of ibandronate sodium
    Publication number: 20090012047
    Abstract: Provided are crystalline forms of ibandronate sodium, as well as processes for the preparation thereof.
    Type: Application
    Filed: November 16, 2007
    Publication date: January 8, 2009
    Inventors: Eran Turgeman, Revital Lifshitz-Liron, Claude Singer, Tamas Koltai
  • Crystal forms of (S)-(+)-N,N-dimethyl-3-(1-Napathalenyloxy)-3-(2-thienyl)propanamine oxalate and the preparation thereof
    Publication number: 20090012316
    Abstract: DNT-Oxal crystalline forms and processes for making DNT-Oxal crystalline forms are provided.
    Type: Application
    Filed: June 16, 2008
    Publication date: January 8, 2009
    Inventors: Santiago Ini, Anita Liberman, Tamas Koltai
  • Crystalline forms of tigecycline and processes for preparation thereof
    Publication number: 20090005453
    Abstract: The present invention provides crystalline forms of Tigecycline, and methods of for preparation of crystalline forms and amorphous.
    Type: Application
    Filed: November 29, 2007
    Publication date: January 1, 2009
    Inventors: Evgeny Tsiperman, Sofia Gorohovsky-Rosenberg, Slavik Yurkovski, Sergei Fine, Tamas Koltai, Sigalit Levi, Leonid Metsger, Michal Rafilovich
  • Crystalline form IV of linezolid
    Publication number: 20080319191
    Abstract: The present invention provides a novel crystalline form of linezolid referred to herein as Form IV as well as methods for the preparation and use of Form IV. The present invention provides pharmaceutical compositions that comprise therapeutically effective amounts of Form IV that can be used to treat patients suffering from gram-positive bacterial infections. Various processes for making crystalline linezolid Form IV are disclosed.
    Type: Application
    Filed: August 22, 2008
    Publication date: December 25, 2008
    Inventors: Judith Aronhime, Tamas Koltai, Viviana Braude, Serguei Fine, Tamar Niddam
  • Processes for preparation of 9-haloacetamidominocyclines
    Publication number: 20080234504
    Abstract: The present invention provides substantially pure intermediates, 9-haloacetomidominocyclines, and process of preparing them that are useful for the preparation of glycylcyclines, specifically Tigecycline.
    Type: Application
    Filed: November 30, 2007
    Publication date: September 25, 2008
    Inventors: Evgeny Tsiperman, Sofia Gorohovsky, Slavik Yurkovski, Sergei Fine, Tamas Koltai, Judith Aronhime